A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2004
11/17/2004	EP1476178A2 Formulation strategies in stabilizing peptides in organic solvents and in dried states
11/17/2004	EP1476177A2 Peptide constructs for treating disease
11/17/2004	EP1476176A2 Transport peptides and uses therefor
11/17/2004	EP1476175A2 Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis
11/17/2004	EP1476156A2 Piperidine or pyrrolidine derivatives having an aminoacyl substituted side chain as melanocortin-4 receptor agonists
11/17/2004	EP1476154A2 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
11/17/2004	EP1476153A2 Method of treating and preventing bone loss
11/17/2004	EP1427439A4 Gamma three protease
11/17/2004	EP1390063B1 Pharmaceutical dosage form of amorphous nelfinavir mesylate
11/17/2004	EP1363658B1 Beta-endorphin / crf - gene therapy for combatting pain locally
11/17/2004	EP1303297B1 Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency
11/17/2004	EP1257261B1 Antiviral pharmaceutical compositions containing iron chelators
11/17/2004	EP1254229B1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof
11/17/2004	EP1252322B1 Herpes virus strains for gene therapy
11/17/2004	EP1176968B1 Selenium-containing pro-drugs for cancer therapy
11/17/2004	EP1168997A4 Vacuum assisted closure system with provision for introduction of agent
11/17/2004	EP1159457A4 T cell receptor vbeta beta-jbeta) sequence and methods for its detection
11/17/2004	EP1137667B1 Analogues of glp-1
11/17/2004	EP1105503B1 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGCALPHA1/BETA1)
11/17/2004	EP1087762B1 Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects
11/17/2004	EP1073733B1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
11/17/2004	EP1073427B1 Periadventitial delivery device
11/17/2004	EP1064064B1 Removal of contaminants from biological products
11/17/2004	EP1037649A4 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
11/17/2004	EP0981369B1 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
11/17/2004	EP0979245B1 Oligopeptidic inhibitors of elastases and methods of preparation thereof
11/17/2004	EP0956293B1 Thrombin inhibitors
11/17/2004	EP0943003B1 Insulin-like growth factor i (igf-i) expression system and methods of use
11/17/2004	EP0933995B1 Method of treating endothelial injury
11/17/2004	EP0920501B8 Neuritin, a neurogene
11/17/2004	EP0907658B1 Neuropeptide y agonists
11/17/2004	EP0904093A4 Administration of polypeptide growth factors following central nervous system ischemia or trauma
11/17/2004	EP0897392B1 Peptides binding sh3 domain of cortactin and their use
11/17/2004	EP0860446B1 Type cc chemokine-like protein
11/17/2004	EP0852502B1 Lantibiotic mutants and chimeras of enhanced stability and activity
11/17/2004	EP0819763B1 Engineered acarid allergen and process for producing the same
11/17/2004	EP0777491B1 Use of tasteless, hydrolysed collagen and agent containing the same
11/17/2004	EP0731811B1 Chaperonin 10
11/17/2004	EP0731106B1 Dolastatin derivatives
11/17/2004	EP0679160B1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis
11/17/2004	CN1547617A Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof
11/17/2004	CN1547608A Modified factor IX
11/17/2004	CN1547586A Increased recovery of active proteins
11/17/2004	CN1547542A Stackable low depth tray
11/17/2004	CN1547486A Antibodies to OPGL
11/17/2004	CN1547484A Pharmaceutical dosage form of amorphous nelfinavir mesylate
11/17/2004	CN1547483A New use of ARTEMIN, a member of the GDNF ligand family
11/17/2004	CN1547482A Use of POLY-GLU,TYR and T cells treated therewith for neuroprotective therapy
11/17/2004	CN1547481A Process for preparing glycopeptide phosphonate derivatives
11/17/2004	CN1547480A Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivati
11/17/2004	CN1547460A Composite powders and skin preparations for external use containing the same
11/17/2004	CN1546662A Recombinant caspase-6 gene having target activity and its uses in treating tumor
11/17/2004	CN1546533A Hericium erinaceus sulfate proteoglycan, preparation method thereof and pharmaceutical compositions with the same as active component
11/17/2004	CN1546528A Fusion protein of kininogen D5 and tumor necrosis factor related apoptosis-inducing ligand(D5-TRAIL), its preparation and use thereof
11/17/2004	CN1546522A Alkaline fibroblast growth factor antigen epitope peptide and its screening method
11/17/2004	CN1546521A Transfer factor specific for SARS virus and method for preparing same
11/17/2004	CN1546171A Protease inhibitor of Ornithotoctonus huwena
11/17/2004	CN1546170A Novel use of recombined human antalzyme atomizing solution and inhalant in resisting drug-fast bacteria in pharmacy
11/17/2004	CN1546169A Transnasal inhalant dry powder of calcitonin and its preparation
11/17/2004	CN1546168A Preparing method of liposome endothelial chalone
11/17/2004	CN1546167A Prescription for preventing and treating fin rot of turbot
11/17/2004	CN1546166A Application of reducing glutathione in pharmacy
11/17/2004	CN1546165A Technique for preparing transfer factor - complete filtering method
11/17/2004	CN1546164A Spraying agent of transfer factor
11/17/2004	CN1176137C Multi-arm fork type functional polyethylene glycol preparation method and its application in medicine
11/17/2004	CN1176105C New anti-embolism medicine using small peptide arginine-glycine-aspartic acid (RGD) as leading compound
11/17/2004	CN1176104C Process for preparation of acetyl-guanylphenylalanyl-cyclohexylglycyl-pyridinioalaninamides
11/17/2004	CN1176099C Natural dissociation essence Gamma gene and antineoplastic active polypeptide dissociation essence Gamma
11/17/2004	CN1176098C Triplex forming oligonucleotides and their use in anti-HBV
11/17/2004	CN1175902C Sucked insulin preparation
11/17/2004	CN1175901C Stable water solution of interferon
11/17/2004	CN1175900C CTLA-4 preparation for eyes
11/17/2004	CN1175899C Medicine composition and preparation and use thereof
11/17/2004	CA2470177A1 System and method for controlling user interface properties with data
11/16/2004	US6818787 Prodrugs of GABA analogs, compositions and uses thereof
11/16/2004	US6818754 For therapy/diagnosis/research; forensics/genetic mapping/mutation detection
11/16/2004	US6818751 Antigen presenting cell expressing prostate-specific protein; for prevention/monitoring
11/16/2004	US6818750 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
11/16/2004	US6818749 Variants of humanized anti carcinoma monoclonal antibody cc49
11/16/2004	US6818746 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and skin disorders
11/16/2004	US6818745 For diagnosis/treatment of tumors; drug screening of antitumor agents; metastatic-tumor excreted phosphaturic-element (mepe/phosphatonin)
11/16/2004	US6818744 For diagnosis/prevention/treatment of neoplasia; antitumor agents
11/16/2004	US6818743 Intercellular adhesion molecule (i-cam) for modulation of ligand/receptor binding/cloning reactions; drug screening of antiinflammatory/anticancer agents; genetic engineering
11/16/2004	US6818741 Alpha-fetoprotein peptides and uses therof
11/16/2004	US6818739 Somatostatins
11/16/2004	US6818738 Pulmonary insulin crystals
11/16/2004	US6818659 Targets and binds biological receptors; medical diagnosis; magnetic resonance, x-ray, ultrasound, and contrast imaging
11/16/2004	US6818623 Active hedgehog protein conjugate
11/16/2004	US6818622 Selective MMP inhibitors having reduced side-effects
11/16/2004	US6818621 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/16/2004	US6818620 Polypeptides
11/16/2004	US6818619 Chimeric natriuretic peptides
11/16/2004	US6818618 Hyperplasia, restenosis, and atherosclerosis treatment with polypeptide
11/16/2004	US6818617 EC-3, an inhibitor of α4β1 and α4β7 integrins
11/16/2004	US6818616 Neutrophil inhibitory factor inhibits adhesion to vascular endothelial cells; genetically engineered polypeptides; may include nematodal glycoprotein; antiinflammatory agents
11/16/2004	US6818615 Antitumor, anticancer agents; synergistic mixture
11/16/2004	US6818614 Compounds having antifungal activity
11/16/2004	US6818613 A parenteral sustained-release formulation of e.g., erythropoietin, that is easily manufactured, safe, stable and efficient comprising the protein, a buffer, tonicity agent and sodium carboxymethylcellulose
11/16/2004	US6818612 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
11/16/2004	US6818611 Stabilized bioactive peptides and methods of identification, synthesis and use

1 ... 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 ... 3163